Market Research
Future (MRFR) announces the publication of its research report – Global
Blepharitis market -2023
Market Highlights
Blepharitis is an ophthalmologic disorder which causes
inflammation of the eyelids that leads to eye irritation. It is a common eye
disorder that is caused by either bacteria or a skin condition like dandruff
from the scalp or overproduction of oil from the glands of the eyelids.
Global Blepharitis Market is expected to grow a healthy growth at
a CAGR of 6.5% during the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5766
Regional Analysis
The Americas dominate the global blepharitis
treatment market owing to the rising ophthalmological disorders, such
as dry eye, uveitis among others and increasing awareness among mass regarding
eye care. Additionally, competitiveness among the major players in the North
America region is likely to enhance the growth of blepharitis in the North
American region. Similarly, growing initiatives and funding’s along with demand
for newer technologies are propelling the growth of blepharitis market in North
America region. For instance, eye care programs such as Eye Care America and
VISION USA aims to provide free eye examinations to eligible and uninsured
people in the North American region.
Europe accounts for the second largest market due to increasing
aging mass and rising rates of eye disorders. Additionally, improving
government initiatives and increasing healthcare frame along with rising demand
for technologically innovative treatment is driving the growth of blepharitis
market in Europe. For instance, Eurostat estimated that over 19.2% of the
population in Europe were aged 65 and above. Additionally, according to the
United Kingdom Statistics Authority, around 121,736 eye examinations were
performed under Eye Health Examinations Wales (EHEW) scheme. This rising older
population and increasing government initiatives are likely to drive the growth
of the blepharitis market.
Asia Pacific is the fastest growing market for blepharitis as it
is developing at a very rapid pace and has shown the emergence of many players.
Additionally, rising prevalence of ophthalmological disorders, increasing
healthcare expenditure and demand for new treatment options along with
multinational companies moving towards the developing nations and setting
operational set-ups are likely to drive the growth of the market. India and
China are the major contributors to the market growth due to the rapid development
of healthcare infrastructure in these regions and increasing demand for
improved healthcare services.
On the other hand, the Middle East & Africa is expected to
witness limited growth due to limited access and lack of awareness among the
population. In the Middle East, the growth of the market is driven by
increasing availability of advanced healthcare scenario.
Segmentation
The
global blepharitis market is segmented on the basis of type, treatment,
diagnosis, and end user.
On
the basis of type, the market is segmented into anterior blepharitis, posterior
blepharitis, and mixed blepharitis.
On
the basis of treatment, the market is segmented into eye cleansers, artificial
tears, and antibiotic therapy. Antibiotic therapy segment is further
sub-segmented into topical antibiotic therapy and oral antibiotic therapy.
On
the basis of diagnosis, the market is segmented into physical examination,
comprehensive eye examination, and others.
On
the basis of the end user, the market is segmented into specialty centers,
hospitals, and others.
Key Players
Some
of the key players in the Blepharitis market are Scope Ophthalmics Ltd, InSite
Vision Incorporated, NovaBay Pharmaceuticals, Inc., Thea Pharmaceuticals
Limited, Perrigo Laboratories, Merck & Co., Galderma S.A., and Novartis AG.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blepharitis-market-5766
No comments:
Post a Comment